Ajanta Pharma Ltd. NSE: AJANTPHARM | BSE: 532331

Mid-range Performer

Download real time

2681.60 -52.90 (-1.93%)

55,916

NSE+BSE Volume

High vol. this week

NSE 26 Dec, 2025 3:31 PM (IST)

Signs Agreement

Ajanta Pharma signs an agreement with Biocon to market Semaglutide with a market size of $26 bn See details

Ajanta Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Ajanta Pharma from all sources in a single place.

Is Ajanta Pharma Ltd. worth buying?

195 Votes:

Buy 76.92%

Sell 16.41%

Hold 6.67%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >